vs

Side-by-side financial comparison of CENTRUS ENERGY CORP (LEU) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $146.2M, roughly 1.4× CENTRUS ENERGY CORP). On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs -3.6%). Varex Imaging Corp produced more free cash flow last quarter ($-26.8M vs $-58.0M). Over the past eight quarters, CENTRUS ENERGY CORP's revenue compounded faster (82.9% CAGR vs 0.8%).

Centrus Energy Corp. is an American company that supplies nuclear fuel for use in nuclear power plants and works to develop and deploy centrifuge technology to produce enriched uranium for commercial and government uses, including for national security.

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

LEU vs VREX — Head-to-Head

Bigger by revenue
VREX
VREX
1.4× larger
VREX
$209.6M
$146.2M
LEU
Growing faster (revenue YoY)
VREX
VREX
+8.5% gap
VREX
4.9%
-3.6%
LEU
More free cash flow
VREX
VREX
$31.2M more FCF
VREX
$-26.8M
$-58.0M
LEU
Faster 2-yr revenue CAGR
LEU
LEU
Annualised
LEU
82.9%
0.8%
VREX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
LEU
LEU
VREX
VREX
Revenue
$146.2M
$209.6M
Net Profit
$2.3M
Gross Margin
23.9%
33.3%
Operating Margin
8.8%
7.3%
Net Margin
1.1%
Revenue YoY
-3.6%
4.9%
Net Profit YoY
866.7%
EPS (diluted)
$0.52
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEU
LEU
VREX
VREX
Q1 26
$209.6M
Q4 25
$146.2M
$228.9M
Q3 25
$74.9M
$203.0M
Q2 25
$154.5M
$212.9M
Q1 25
$73.1M
$199.8M
Q4 24
$151.6M
Q3 24
$57.7M
$205.7M
Q2 24
$189.0M
$209.1M
Net Profit
LEU
LEU
VREX
VREX
Q1 26
$2.3M
Q4 25
$12.2M
Q3 25
$3.9M
$-89.1M
Q2 25
$28.9M
$6.9M
Q1 25
$27.2M
$-300.0K
Q4 24
Q3 24
$-5.0M
$-51.1M
Q2 24
$30.6M
$1.4M
Gross Margin
LEU
LEU
VREX
VREX
Q1 26
33.3%
Q4 25
23.9%
34.0%
Q3 25
-5.7%
33.3%
Q2 25
34.9%
36.0%
Q1 25
45.0%
34.3%
Q4 24
40.8%
Q3 24
15.4%
32.6%
Q2 24
19.3%
32.0%
Operating Margin
LEU
LEU
VREX
VREX
Q1 26
7.3%
Q4 25
8.8%
8.6%
Q3 25
-22.2%
-39.8%
Q2 25
21.7%
10.4%
Q1 25
28.0%
5.6%
Q4 24
29.7%
Q3 24
-13.2%
5.3%
Q2 24
11.2%
4.4%
Net Margin
LEU
LEU
VREX
VREX
Q1 26
1.1%
Q4 25
5.3%
Q3 25
5.2%
-43.9%
Q2 25
18.7%
3.2%
Q1 25
37.2%
-0.2%
Q4 24
Q3 24
-8.7%
-24.8%
Q2 24
16.2%
0.7%
EPS (diluted)
LEU
LEU
VREX
VREX
Q1 26
$0.05
Q4 25
$0.52
$0.29
Q3 25
$0.19
$-2.15
Q2 25
$1.59
$0.17
Q1 25
$1.60
$-0.01
Q4 24
$3.26
Q3 24
$-0.30
$-1.25
Q2 24
$1.89
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEU
LEU
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$2.0B
$125.6M
Total DebtLower is stronger
$1.2B
$367.6M
Stockholders' EquityBook value
$765.1M
$476.9M
Total Assets
$2.4B
$1.1B
Debt / EquityLower = less leverage
1.54×
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEU
LEU
VREX
VREX
Q1 26
$125.6M
Q4 25
$2.0B
$155.1M
Q3 25
$1.6B
$152.6M
Q2 25
$833.0M
$223.0M
Q1 25
$653.0M
$212.6M
Q4 24
$671.4M
Q3 24
$194.3M
$200.5M
Q2 24
$227.0M
$190.0M
Total Debt
LEU
LEU
VREX
VREX
Q1 26
$367.6M
Q4 25
$1.2B
$367.5M
Q3 25
$1.2B
$367.5M
Q2 25
$390.0M
$567.2M
Q1 25
$389.5M
$567.0M
Q4 24
$472.5M
Q3 24
$83.5M
$443.4M
Q2 24
$86.5M
$443.1M
Stockholders' Equity
LEU
LEU
VREX
VREX
Q1 26
$476.9M
Q4 25
$765.1M
$472.6M
Q3 25
$363.1M
$455.3M
Q2 25
$359.1M
$549.7M
Q1 25
$213.9M
$540.2M
Q4 24
$161.4M
Q3 24
$76.4M
$529.1M
Q2 24
$76.6M
$581.2M
Total Assets
LEU
LEU
VREX
VREX
Q1 26
$1.1B
Q4 25
$2.4B
$1.1B
Q3 25
$2.2B
$1.1B
Q2 25
$1.3B
$1.4B
Q1 25
$1.3B
$1.3B
Q4 24
$1.1B
Q3 24
$591.0M
$1.2B
Q2 24
$668.2M
$1.3B
Debt / Equity
LEU
LEU
VREX
VREX
Q1 26
0.77×
Q4 25
1.54×
0.78×
Q3 25
3.23×
0.81×
Q2 25
1.09×
1.03×
Q1 25
1.82×
1.05×
Q4 24
2.93×
Q3 24
1.09×
0.84×
Q2 24
1.13×
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEU
LEU
VREX
VREX
Operating Cash FlowLast quarter
$-48.4M
$-16.1M
Free Cash FlowOCF − Capex
$-58.0M
$-26.8M
FCF MarginFCF / Revenue
-39.7%
-12.8%
Capex IntensityCapex / Revenue
6.6%
5.1%
Cash ConversionOCF / Net Profit
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$31.3M
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEU
LEU
VREX
VREX
Q1 26
$-16.1M
Q4 25
$-48.4M
$7.9M
Q3 25
$10.1M
$7.7M
Q2 25
$52.8M
$16.6M
Q1 25
$36.5M
$9.5M
Q4 24
$57.9M
Q3 24
$-33.2M
$25.9M
Q2 24
$7.0M
$8.0M
Free Cash Flow
LEU
LEU
VREX
VREX
Q1 26
$-26.8M
Q4 25
$-58.0M
$2.3M
Q3 25
$5.7M
$1.4M
Q2 25
$49.2M
$9.8M
Q1 25
$34.4M
$5.3M
Q4 24
$57.2M
Q3 24
$-34.2M
$19.9M
Q2 24
$6.1M
$3.3M
FCF Margin
LEU
LEU
VREX
VREX
Q1 26
-12.8%
Q4 25
-39.7%
1.0%
Q3 25
7.6%
0.7%
Q2 25
31.8%
4.6%
Q1 25
47.1%
2.7%
Q4 24
37.7%
Q3 24
-59.3%
9.7%
Q2 24
3.2%
1.6%
Capex Intensity
LEU
LEU
VREX
VREX
Q1 26
5.1%
Q4 25
6.6%
2.4%
Q3 25
5.9%
3.1%
Q2 25
2.3%
3.2%
Q1 25
2.9%
2.1%
Q4 24
0.5%
Q3 24
1.7%
2.9%
Q2 24
0.5%
2.2%
Cash Conversion
LEU
LEU
VREX
VREX
Q1 26
-7.00×
Q4 25
0.65×
Q3 25
2.59×
Q2 25
1.83×
2.41×
Q1 25
1.34×
Q4 24
Q3 24
Q2 24
0.23×
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEU
LEU

Separative Work Units$111.0M76%
Services$21.8M15%
Other$13.4M9%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons